|
|
Statistics
Categories: 160
Subcategories: 0
Total Posts/Links: 3622
Pending: 1
Today: 0
|
|
|
| ID: | 1555 | | Title: | Press Release Distorts Raloxifene Results - http://www.breastcancer-treatment.us/content/view/66/ | | Description: | Tamoxifen (sold in the US as Nolvadex®) is a useful drug. It can reduce the chance of developing breast cancer in women who are at high risk of that disease, and can also diminish the chance of recurrence in some patients who have been successfully treated for breast cancer. Unfortunately, tamoxifen also has some serious side effects, the most significant of which are an increased risk of thrombosis (blood clots) and a heightened chance of a particularly aggressive form of uterine cancer. Scientists have therefore been looking for similar drugs that would have the benefits of tamoxifen but with fewer dangerous side effects. . | | Category: | Breast Cancer | | Link Owner: | | | Date Added: | October 17, 2006 11:02:00 AM | | Number Hits: | 0 | | |
|
